MACKENZIE GRAY: Open Payments
NPI 1205536828 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 11 payments from 8 companies in 2025. Trend: 2023 $377 · 2024 $117 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Alkermes, Inc. | 1 | $26 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Corium, LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: UZEDY, ABILIFY MAINTENA, FANAPT, ARISTADA, ERZOFRI EXTENDED-RELEASE, INGREZZA, Azstarys, CAPLYTA.
Industry payments across IN — which companies pay providers there.
